These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24947205)

  • 1. Heterogeneous pattern of bone disease in adult type 1 Gaucher disease: clinical and pathological correlates.
    van Dussen L; Lips P; van Essen HW; Hollak CE; Bravenboer N
    Blood Cells Mol Dis; 2014 Sep; 53(3):118-23. PubMed ID: 24947205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease.
    van Dussen L; Lips P; Everts VE; Bravenboer N; Jansen ID; Groener JE; Maas M; Blokland JA; Aerts JM; Hollak CE
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2194-205. PubMed ID: 21543432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far.
    Komninaka V; Kolomodi D; Christoulas D; Marinakis T; Papatheodorou A; Repa K; Voskaridou E; Revenas K; Terpos E
    Eur J Haematol; 2015 Oct; 95(4):342-51. PubMed ID: 25645321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
    Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal aspects of Gaucher disease: a review.
    Wenstrup RJ; Roca-Espiau M; Weinreb NJ; Bembi B
    Br J Radiol; 2002; 75 Suppl 1():A2-12. PubMed ID: 12036828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marker alterations in patients with type 1 Gaucher disease.
    Ciana G; Martini C; Leopaldi A; Tamaro G; Katouzian F; Ronfani L; Bembi B
    Calcif Tissue Int; 2003 Mar; 72(3):185-9. PubMed ID: 12522660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease.
    Ivanova MM; Dao J; Loynab N; Noor S; Kasaci N; Friedman A; Goker-Alpan O
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
    Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
    Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone manifestations of Gaucher's disease in Mexican patients].
    Blass PJ
    Acta Ortop Mex; 2010; 24(5):351-8. PubMed ID: 21246808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do serological tissue turnover markers represent callus formation during fracture healing?
    Seebeck P; Bail HJ; Exner C; Schell H; Michel R; Amthauer H; Bragulla H; Duda GN
    Bone; 2005 Nov; 37(5):669-77. PubMed ID: 16126014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
    J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Study of Bone Manifestations in Adult Gaucher Disease Type 1 Patients in Argentina.
    Oliveri B; González D; Quiroga F; Silva C; Rozenfeld P
    Calcif Tissue Int; 2019 Jun; 104(6):650-657. PubMed ID: 30790003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
    Withold W
    Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):785-99. PubMed ID: 8933101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease and multiple myeloma.
    Costello R; O'Callaghan T; Sébahoun G
    Leuk Lymphoma; 2006 Jul; 47(7):1365-8. PubMed ID: 16923570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.